Saliga, Edna .

HRN: 17-92-49  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2026
CEFUROXIME 500MG (TAB)
06/11/2026
06/17/2026
IV
500ng
Bid
Prom 13h
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: